Your browser doesn't support javascript.
loading
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram.
Pietrantonio, F; Miceli, R; Rimassa, L; Lonardi, S; Aprile, G; Mennitto, A; Marmorino, F; Bozzarelli, S; Antonuzzo, L; Tamburini, E; Morano, F; Rossini, D; Battaglin, F; Baretti, M; Berenato, R; Formica, V; Mosconi, S; Petrelli, F; Ghidini, M; Loupakis, F; Spada, D; Cinieri, S; Beretta, G; Falcone, A; de Braud, F; Cremolini, C.
Afiliación
  • Pietrantonio F; Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy.
  • Miceli R; Trial Office and Biomedical Statistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Rimassa L; Medical Oncology and Hematology Unit, Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan.
  • Lonardi S; Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Istituto Oncologico Veneto - IRCCS, Padova.
  • Aprile G; Department of Oncology, University and General Hospital, Udine.
  • Mennitto A; Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy.
  • Marmorino F; Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa.
  • Bozzarelli S; Medical Oncology and Hematology Unit, Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan.
  • Antonuzzo L; S.C. Oncologia Medica 1, Azienda Ospedaliero Universitaria Careggi, Firenze.
  • Tamburini E; Department of Medical Biotechnologies, University of Siena, Siena.
  • Morano F; Medical Oncology Unit, Rimini Hospital, Rimini.
  • Rossini D; Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy.
  • Battaglin F; Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa.
  • Baretti M; Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Istituto Oncologico Veneto - IRCCS, Padova.
  • Berenato R; Medical Oncology and Hematology Unit, Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan.
  • Formica V; Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy.
  • Mosconi S; Medical Oncology Unit, Policlinico Tor Vergata University Hospital, Roma.
  • Petrelli F; Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo.
  • Ghidini M; Department of Oncology, ASST Bergamo Ovest, Treviglio, Bergamo.
  • Loupakis F; Division of Medicine and Medical Oncology, Azienda Istituti Ospitalieri, Cremona.
  • Spada D; Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Istituto Oncologico Veneto - IRCCS, Padova.
  • Cinieri S; ASL Lecce-Presidio Ospedaliero Vito Fazzi, UOC Oncologia Medica, Lecce.
  • Beretta G; Medical Oncology, Hospital A. Perrino, Brindisi.
  • Falcone A; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo.
  • de Braud F; Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa.
  • Cremolini C; Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy.
Ann Oncol ; 28(3): 555-561, 2017 03 01.
Article en En | MEDLINE | ID: mdl-27864220

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Análisis Costo-Beneficio / Nomogramas Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Análisis Costo-Beneficio / Nomogramas Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Italia